Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti infectives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel ionic liquid catalyzed synthesis of Prulifloxacin. High purity API intermediate manufacturing with reduced environmental impact and scalable processes.
Patent CN101633643A details a high-yield Boron trifluoride catalyzed synthesis of Ornidazole, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.